Hospital Edouard Herriot

Lyon Cedex 03

0 studies enrolling now · 3 studies all time

What they study most

Fabry Disease, Myelodysplastic Syndromes, Pyoderma Gangrenosum

Studies at this site

• Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum — Stopped early
• A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care — Completed
• A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease — Completed